Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

37.14
Delayed Data
As of Apr 24
 +0.56 / +1.53%
Today’s Change
30.13
Today|||52-Week Range
52.58
-26.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line1.6M1.4M9.6M34.4M
 
 
 
 
 
Depreciation499.0K172.0K221.0K352.0K
 
 
 
 
 
Total Other Cash Flow24.4M21.0M64.0K-12.4M
 
 
 
 
 
Funds From Operations26.4M22.5M9.9M22.4M
 
 
 
 
 
Funds From/For Other Operating Expenses2.4M-93.0K-741.0K2.3M
 
 
 
 
 
Net Cash Flow - Operating Activities24.0M22.6M10.7M20.2M
 
 
 
 
 
 
InvestingIncrease In Investments-33.6M-47.7M-115.9M-98.4M
 
 
 
 
 
Decrease In Investments16.8M28.7M47.3M99.9M
 
 
 
 
 
Capital Expenditures-445.0K-252.0K-606.0K-1.0M
 
 
 
 
 
Fixed Asset Disposal9.0K66.0K0.003.0K
 
 
 
 
Other Investing - Uses-436.0K0.000.000.00
 
 
Other Investing - Sources0.001.1M0.000.00
 
 
Net Cash Flow Investing-17.7M-18.0M-69.2M497.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale34.0K141.0K56.9M1.1M
 
 
 
 
 
Common Preferred Redeemed0.00-1.1M0.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00110.0K
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing34.0K-909.0K56.9M1.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash6.4M3.7M-1.7M21.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account